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Background: Depressive disorders are highly prevalent and result in negative consequences for both patients and
society. It is therefore important that these disorders are treated adequately. However, due to increased demand for
mental healthcare and subsequent increased costs, it would be desirable to reduce costs associated with major
depressive disorder while maintaining or improving the quality of care within the healthcare system. Introducing
evidence-based online self-help interventions in mental healthcare might be the way to maintain clinical effects
while minimizing costs by reducing the number of face-to-face sessions. This study aims to evaluate the clinical and
economical effects of a guided online self-help intervention when offered to patients with major depressive disorder
on a waiting list for psychotherapy in specialized mental health centers (MHCs).
Methods: Patients at mental health centers identified with a Diagnostic and Statistical Manual of Mental Disorders,
fourth edition (DSM-IV) diagnosis of major depression who are awaiting face-to-face treatment are studied in a
randomized controlled trial. During this waiting list period, patients are randomized and either (1) receive an
internet-based guided self-help treatment or (2) receive a self-help book. The 5-week internet-based guided self-help
intervention and the self-help booklet are based on problem solving treatment. After the intervention, patients are
allowed to start regular face-to-face treatment at MHCs. Costs and effects are measured at baseline, after the
intervention at 6 to 8 weeks, 6 months and 12 months. The primary outcome measure is symptoms of depression.
Secondary outcome measures are diagnosis of depression, number of face-to-face sessions, absence of work and
healthcare uptake in general. Additional outcome measures are anxiety, insomnia, quality of life and mastery.
Discussion: This study evaluates the effectiveness and cost effectiveness of internet-based guided self-help in patients
at specialized mental health centers. The aim is to demonstrate whether the introduction of internet-based self-help
interventions in regular mental healthcare for depressive disorders can maintain clinical effects and reduce costs.
Strengths and limitations of this study are discussed.
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Specialized mental healthcareBackground
Depressive disorders are highly prevalent [1-3], and are as-
sociated with high costs in the professional, social, per-
sonal and financial realms [1,3,4]. Those suffering from
depression are more often absent from work, and have
higher levels of healthcare consumption compared to
healthy individuals [2]. It is desirable from a clinical point
of view to reduce the burden of depression, as it is from a
societal point of view to reduce the economic costs related
to increased healthcare uptake, and reduced work prod-
uctivity. In addition, given the increased demand for men-
tal healthcare and limitation of recourses, it is important
for mental health centers to optimize the efficient and ef-
fective use of resources.
In The Netherlands, a person with symptoms of depres-
sion who is seeking help is most likely to be seen first by a
general practitioner (GP) [5], who acts as a gatekeeper for
referral to specialized mental health services. After regis-
tration at a mental health service, patients usually have an
assessment and are then assigned to a specific treatment.
The time between registration and the first treatment ses-
sion is normally at least 6 weeks. Long waiting lists caused
by low workforce numbers are common. This time might
be used to deploy internet-based self-help treatments
[6,7], as previous studies have indicated that internet-
based self-help therapies are clinically effective in diverse
populations [8-11]. Internet-based treatments require less
therapist time in comparison with standard face to face
treatments and can therefore offer potential solutions as
they are immediately accessible, less costly and put less
strain on therapeutic resources. They might serve first
step in a stepped delivery of care. This means that only
those who do not respond adequately step up to a treat-
ment of higher intensity, in this case the regular treatment
in mental health centers. This stepped-care approach is
suggested in several guidelines such as the Australian and
National Institute for Health and Care Excellence (NICE)
guidelines for depression, which recommend that patients
receive the least burdensome treatment. Psychological
treatments such as computerized cognitive behavioral
therapy (cCBT) and individual guided self-help programs
are recommended as low intensity treatments. After re-
ceiving such treatments, patients possibly need fewer or
no face-to-face sessions.
With the current cuts in healthcare budgets, it would be
desirable to reduce costs associated with major depressive
disorder while maintaining or improving the quality ofcare. Introducing evidence-based internet-based self-help in-
terventions in mental healthcare might be the way to speed
up clinical recovery while minimizing costs by reducing the
number of face-to-face sessions. However, internet-based
guided self-help interventions are currently not offered as a
first step to those waiting for specialized mental healthcare.
In the current study, we offer an internet-based guided
self-help program to patients on a waitlist for psycho-
logical treatment. The self-help program is based on
problem-solving therapy and uses self-examination ther-
apy as a general framework [12]. This method has been
found to be effective in several studies in the US [13],
and for this study we used a guided self-help program
that has been examined in two earlier trials, and has
proved its effectiveness in reducing depressive symptoms
in community samples [14,15].
Aims and hypotheses
This study aims to establish the effectiveness of an
internet-based guided self-help intervention for patients
with major depressive disorder before face-to-face treat-
ment in specialized mental healthcare in comparison to a
control group who are on a waitlist for face-to-face treat-
ment. Furthermore, we expect that offering internet-based
treatment as a first step of care reduces costs as we predict




The study is a randomized controlled trial with an eco-
nomic evaluation. We are currently enrolling 248 pa-
tients over 2 large mental health centers (MHCs) in 10
different locations. We will recruit patients directly after
registration for regular face-to-face mental health ser-
vices who need to wait for at least 6 weeks before their
first treatment session. They will be randomized to ei-
ther an internet-based guided self-help intervention or
the regular waitlist before the first treatment session.
People on the waitlist will receive a self-help book with-
out additional guidance in order to motivate them to
participate in the randomize, controlled trial (RCT).
Both groups are allowed to receive regular face-to-face
(FTF) therapy at the MHCs after the waitlist period.
Participants in both groups complete assessment at base-
line, at intervention or waiting list (WL) completion
(6 to 8 weeks), at a 6-month follow-up, and at 12 months.
Kenter et al. Trials 2013, 14:412 Page 3 of 10
http://www.trialsjournal.com/content/14/1/412The protocol of this study has been approved by the
Medical Ethics Committee of the VU University Medical
Center (registration number 2011/223).
Inclusion and exclusion criteria
Eligible participants are adults, aged 18 or over, registering
for regular treatment at one of the participating MHCs
who meet the criteria for a Diagnostic and Statistical
Manual of Mental Disorders, fourth edition (DSM-IV)
diagnosis of major depression as measured with the Cli-
nical International Diagnostic Interview (CIDI) by a trained
research assistant, have access to the internet, and adequate
proficiency in Dutch. Exclusion criteria are starting or
changing type of dosage of antidepressant medication, the
presence of a bipolar or psychotic disorder, and an in-
creased risk of suicide. Comorbid disorders other than bi-
polar or psychotic disorders are allowed.
Recruitment
Participants will be recruited while registering at the
participating MHCs. In routine care patients are briefly
scanned by the MHCs (according to MHCs protocol to
screen out patients who are in crisis and need immediate
treatment), and for the purpose of this study, patients
with mood problems who are eligible for an intake as-
sessment are asked by the MHC to share their contact
details with the researchers. Those who are willing to do
so, will then be called by a member of the research team
who further explains the aim of this study and performs
an additional check of the inclusion and exclusion cri-
teria. If eligible, patients receive a study brochure and an
informed consent form. Patients will only be included in
the study if they meet all the criteria, and sign the in-
formed consent form. In order to confirm the diagnoses
Major Depressive Disorder trained interviewers conduct
a clinical interview (CIDI).
Sample size
The trial is powered to detect an effect size of d ≥0.40
[10,16] as statistically significant in a two-tailed test with
α = 0.05 and power of (1 - β =) 0.80 with N = 99 per con-
dition. To compensate for loss of follow-up of 20%, the
trial requires starting with 99/0.8 = 124 participants per
condition at baseline. The dropout rate of 20% is con-
servative, but from a power perspective a cautious
approach. As this trial has two conditions, a total of
N = 248 will be necessary for the complete trial.
Mental health centers characteristics
Two MHCs will be participating in this research. They
each offer services at a number of different locations. In
this trial, a total of ten locations will participate. These
centers are chosen for pragmatic purposes, as they have a
high number of patient enrolment, and have participatedin prior research of the VU University. In general, patients
are referred by their general practitioner to the mental
health centers where the patients is screened and placed
on a waiting list. Within 6 weeks an initial meeting with a
therapist takes place in which the patient’s needs and pref-
erences regarding to treatment are determined. At these
participating MHCs it normally takes between 7 to 16
weeks for patients to have a first treatment session, de-
pending on therapist workload, treatment modality and
other factors. Treatment in both centers can consist of
psychological therapies such as CBT, sometimes in com-
bination with medication. The researchers are not in-
volved in the face-to-face treatment, and neither in the
decision-making process. However, prior to the start of
this study all therapists at the participating MHCs will be
informed about the goals of this study and the internet-
based intervention, they will attend a Q&A session with
the first author and receive the self-help book containing
the intervention. Prior to the start of a patients’ face-to-
face treatment at the MHC the therapists will be informed
by the aforementioned note in electronic patient record
and through email that their patients are participating in
this study. One of the objectives of the internet-based
intervention is that the subsequent face-to-face treatment
can be adjusted to fewer sessions. The number and type of
therapeutic sessions patients will receive is based on the
needs of the patient, the judgment of the therapist, and
protocol available at the MHC. The type and number of
sessions will therefore vary per participant, and are outside
the control of the researchers.
Internet intervention
The internet intervention that will be used is called ‘Tak-
ing Control’ (original title: ‘Alles Onder Controle’). This
intervention uses the self-examination treatment model
developed by Bowman and colleagues [12,13], which
is based on problem-solving therapy and uses self-
examination therapy (SET) as a general framework. We
translated it into Dutch, elaborated on it, and added infor-
mation and exercises. We built a website for this interven-
tion and developed a system for email support. This
intervention has been described in more detail in several
other studies [12-14].
In brief, this intervention is short, structured and man-
ualized. It consists of five weekly sessions. Each session
contains a structured homework assignment to be com-
pleted by the participant. The first session requires par-
ticipants to consider what is important in their lives.
Next to this, participants will make a list of current
problems and worries in their lives. This first session
helps participants to divide their problems into the fol-
lowing three categories: not important (if the problem is
not related to the list of important things), important
and unsolvable (for example, permanent loss of health
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ond, third and fourth session participants will be offered
various coping skills related to each of the categories of
problems; the main focus is placed on adopting a struc-
tured six-step approach when encountering important,
solvable problems. This structured approach is divided
in the following steps: identifying the current problem;
finding possible solutions; selecting one solution; create
a plan to solve the problem with this solution; execute
the plan and evaluate the plan. The last week of the
intervention is reserved for both the reflection on long-
term goals and the development of a structure to achieve
these goals. Participants can only move on to the next ses-
sion once the exercise in the current session has been
submitted and when feedback on this session has been
released by the research team.
The participants are supported by a coach, who gives
feedback to the homework assignments of the partici-
pants in brief, weekly emails. The total amount of time
spent on each patient is about 1.5 h (estimate based on
our earlier trials). The writing of these emails takes
about 15 or 20 minutes per week, and will be per-
formed by a coach. The coaches will be trained by the
psychologists who have developed the intervention and
also wrote the protocol for giving feedback to ensure
the consistency and integrity. An independent psych-
ologist will verify whether the coaches have followed
the protocol sufficiently by reading a random selection
of the feedback emails.
The feedback has two purposes. Firstly, coaches will
help participants to become familiar with the pre-
sented techniques. The second purpose consists of
motivating the participant to continue with the in-
tervention. Feedback will be received by participants
within 3 working days after a session has been com-
pleted and submitted. When participants pose content
related questions to their coaches via the website,
email or phone, their coaches will provide additional
guidance after receiving the question. After 5 weeks of
guidance, patients can continue to use the internet-
based treatment but will not receive any feedback on
their assignments.
Control condition
To increase participation rates in the control group, this
group receives an unguided self-help book posted to
their home address. This control group will not receive
any feedback from coaches, nor will it have the opportunity
to pose questions. Earlier research shows that self-help
without any form of guidance only results in a small effect
on participants with increased levels of depressive symp-
toms [16].
Participants in both conditions will be referred for
regular FTF treatment after registration at the MHC.FTF treatment might consist of additional waiting time;
the duration of the waiting time is highly variable with a
minimum of 7 weeks and a maximum of 16 weeks de-
pending on the location of MHC. Variation fluctuates
both between locations and over time within the centers,
due to availability of therapists. In case the waiting time
for any MHC falls below 8 weeks, new participants from
this MHC will be temporarily excluded from participat-
ing in the research until the waiting time for new pa-
tients at this MHC exceeds 8 weeks again. This has been
decided in order to not measure the effects of active
treatment by the MHCs at the first post-intervention
test at 8 weeks.
The researchers of this study do not influence the
waiting time at the MHCs, nor will participation in this
study influence the waiting time for the participants.
Randomization and blinding
The random allocation sequence will be generated by an
independent researcher in the program ‘Random Alloca-
tion Software’ , stratified by location using blocks of six,
eight and ten. After each inclusion another independent
researcher will allocate the patient to either the interven-
tion or the control condition. Due to the nature of the
intervention the treatment group allocation cannot be
concealed from the participants, nor from the research
team and assessor of outcomes. Participants are assigned
to one of two conditions within 2 working days from
their baseline assessment Figure 1.
Assessments
This study will utilize both clinical and economical out-
come measures (see Table 1). Assessments take place at
baseline (before randomization), follow-up assessments
are at post-intervention (6 to 8 weeks), and at 6 and 12
months after baseline.
Outcome measures
Our primary outcome will be symptoms of depression.
Secondary outcomes are DSM-IV diagnosis of depres-
sion, number of face-to-face sessions in MHC, costs (in
terms of all healthcare use and work absenteeism), anx-
iety, mastery, insomnia, quality of life, and satisfaction.
Plausible moderators measured in this study will be al-
cohol use, personality, demographic factors and client
expectations.
Because the Composite International Diagnostic Inter-
view (CIDI) is part of the questionnaires at baseline and
at post-intervention assessment (Table 1), the baseline
questionnaires and the 6 to 8 week assessment will be
administered by phone. Follow-up assessments at 6 and
12 months will be administered online. All question-
naires will be in Dutch.
Referral to MHC by GP
Brief screening by MHC RT electronically receive details of potential participants from MHCs
Screening of potential participants by RT by checking for exclusion criteria
Exclusion Criteria:
1. Not willing to sign IC
2. Instable use of medication
3. No current DSM IV disorder
4. Suicidal ideation
5. Bipolar or psychotic disorder
T0: Baseline measurements
Randomisation
Internet-based intervention Self-help book
Week 1-5:  Online treatment with coach Waiting list
Week 8: T1 Assessment: Post-treatment
Start Psychological Treatment As Usual at MHC
for both groups
Week 26: T2 Assessment: Follow-up I
Week 52: T3 Assessment: Follow-up II
RT= Research Team
MHCs= Mental Health Centers
IC= Informed Consent
Figure 1 Study flow chart.
Kenter et al. Trials 2013, 14:412 Page 5 of 10
http://www.trialsjournal.com/content/14/1/412Primary outcome
Symptoms of depression
Symptoms of depression will be registered by using the
Center for Epidemiological Studies Depression scale
(CES-D) [17]. This scale consists of 20 items, the total
score ranges between 0 and 60; higher scores indicate
higher levels of depression and a score of 16 and above in-
dicates a clinical level of depression. This questionnaire
has been tested in various populations and has been found
valid and reliable [18]. A Dutch version of the CES-D has
been validated for internet administration [19].
Secondary outcomes
Diagnosis of depression
The CIDI will be used to assess whether the DSM-IV
diagnosis of depression has been met. The CIDI has beendeveloped by the World Health Organization to assess
DSM-IV Axis-I diagnoses [20]. For the purposes of this
study, only section E will be administered, which allows
for screening for depressive disorders. The CIDI will be
conducted by phone by a trained interviewer.
Symptoms of anxiety
The subscale Anxiety of the Hospital Anxiety and De-
pression Scale (HADS) will be used to measure symp-
toms of anxiety. The depression scale will not be
utilized in this research because depression will be
measured by both CIDI and CES-D. The Anxiety sub-
scale consists of 7 items, which scores range from 0 to
21; higher scores indicate higher levels of anxiety [21].
The HADS has shown to be reliable in Dutch popula-
tions [21].
Table 1 Outcome measures









CES-D Symptoms of depression X X X X
Secondary outcomes
CIDI (Section E) Diagnosis of depression X X
HADS
(Anxiety section)
Symptoms of anxiety X X
ISI Level of insomnia X X
EQ-5D Quality of life X X X X
Resource use
F2F Number of face-to-face appointments
in MHC
X
TiC-P General health service uptake and
productivity losses
X X X X
Mediator
Mastery scale Mastery X X X X
Moderators
Demographic factors User characteristics X
NEO-FFI
(sections N + C)
Neuroticism and conscientiousness traits X
CAGE Alcohol consumption X
CEQ Expectancy and treatment X
AOCEQ Expectations of the internet intervention X
CSQ-8 Client satisfaction with treatment X
AOCSQ Satisfaction with type of intervention X
AOCEQ ‘Alles Onder Controle’ Expectation Questionnaire, AOCSQ ‘Alles Onder Controle’ Satisfaction Questionnaire, CAGE ‘Cutting down, Annoyance by criticism, Guilty
feeling, and Eye-openers’, CEQ Credibility/Expectancy Questionnaire, CES-D Center for Epidemiological Studies Depression scale, CIDI Composite International Diagnostic
Interview, CSQ-8 Client Satisfactory Questionnaire-8, EQ-5D EuroQol 5-Dimensions, F2F face-to-face, ISI Insomnia Severity Index, HADS Hospital Anxiety Depression Scale,
MHC mental health center, NEO-FFI NEO-Five Factor Inventory, TiC-P Trimbos and iMTA Questionnaire on Costs Associated with Psychiatric Illness.
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The perceived level of insomnia will be measured by
the Insomnia Severity Index (ISI) [22]. This question-
naire measures both the concerns associated with the
perceived level of insomnia, as well as symptoms and
consequences of insomnia. Each item is rated on a 0 to
4 scale; a higher score indicates more severe insomnia.
ISI has been found to be internally consistent and reli-
able [22].Quality of life
The EuroQol 5-Dimensions questionnaire (EQ-5D),
which consists of five items, will be used to measure
quality of life. It registers the level of perceived prob-
lems (no, some or extreme) in five domains (mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression). A total of 486 distinct health states can be
scored which are located between 0, which indicatesworst health possible, and 1, which indicates perfect
health [23].Resource use
Costs related to the intervention
Costs related to the intervention will be calculated
based on the costs of running the intervention in both
conditions. To calculate costs related to the internet
intervention, the costs of running the website plat-
form and the costs of the hours of coaching invested
in the intervention will be taken into account. Add-
itional costs in the control group are the publishing of
the self-help books.Costs related to mental healthcare
Costs related to mental healthcare will be measured as
the reported number and type of sessions by the MHC.
This information is sent to the first author 12 months
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ect costs of the sessions will be calculated based on the
Dutch standard cost prices [24].
Costs from a societal perspective
Healthcare costs in general as well as productivity lo-
sses will be measured with the revised version of the
Trimbos and iMTA Questionnaire on Costs Associated
with Psychiatric Illness (TiC-P). Direct costs will be
measured by investigating which contact with health
professionals has occurred and which type of medica-
tion has been prescribed. Indirect costs will be mea-
sured by work absenteeism and reduced productivity.
The baseline TiC-P measures the care consumption 4
weeks prior to the intervention. The follow-up assess-
ments at 6 and 12 months use a 14 and 26 weeks recall
period respectively. Previous research has shown that
up until half a year later, patients can reliably recall
their consumption of health services [25]. The TiC-P
has been used previously in a population with depres-
sive symptoms in The Netherlands [26].
Mediator
Mediator
The amount of perceived control in a person’s life will
be measured by the Pearlin Mastery Scale [27]. The
scale consists of seven distinct items that are rated on
a four-point scale. Higher scores indicate more per-
ceived control; scores range from 7 to 35. The scale
has good reliability [27].
Moderators
Demographics
Demographic variables such as age, gender, parental na-
tionality, family composition, family income and educa-
tional level will be screened for in a general questionnaire
that measures user characteristics.
Alcohol use
The use of alcohol will be monitored using the four ques-
tions that make up the acronym CAGE: ‘Cutting down,
Annoyance by criticism, Guilty feeling, and Eye-openers’
[28]. The CAGE is a widely used concise screening tool
for problematic alcohol consumption [29].
Personality
In order to measure the constructs neuroticism and con-
scientiousness, the NEO-Five Factor Inventory (NEO-FFI)
will be administered [30]. Previous research has indi-
cated that neuroticism often coincides with depression
(for example, [31]). Those scoring higher on conscien-
tiousness are expected to adhere better to the homework
exercises and consequently benefit more from internet-
based therapies. Only these two domains will be testedfor to not exhaust participants more than necessary. A
total of 12 questions on each of the domains will be an-
swered on a 5-point Likert scale.
General expectancy
The Credibility/Expectancy Questionnaire of Devilly
and Borkovec (CEQ) will be used to measure the ex-
pected change and credibility of proposed treatment
[32]. It consists of six questions; four questions meas-
ure the ‘thinking’ aspects about the treatment, two
questions measure the ‘feeling’ aspects of the questions.
One question in both the ‘feeling’ and ‘thinking’ do-
main is rated from 0% to 100%; the remaining four
questions are rated on a Likert-type scale from 1 to 9.
Both factors have been found to have a high internal
consistency and to have high test-retest reliability [32].
Expectancy with internet intervention
The ‘Alles Onder Controle’ Expectancy Questionnaire
(AOCEQ) has been designed for this research to ask
what participants’ expectations are about the course. An
open question investigates in which ways participants
expect to gain benefits from this course. Three five-
point Likert scale questions measure to which degree
participants appreciate starting with the intervention im-
mediately, that personalized feedback will be given in
the internet group and to which degree they expect the
course to help them feel less miserable.
General satisfaction with treatment
The satisfaction with the internet intervention will be
measured by the Client Satisfactory Questionnaire-8
(CSQ-8), which consists of eight questions, each ques-
tion is scored on a Likert-type scale from 1 to 4 [33].
The questionnaire addresses several elements that con-
tribute to overall service satisfaction and is reported in a
single dimension of overall satisfaction. A high internal
consistency has been reported [33].
Satisfaction with the internet intervention
The ‘Alles Onder Controle’ Satisfaction Questionnaire
(AOCSQ) has been designed specifically to investigate to
what degree participants are satisfied with this internet-
based intervention. It includes questions on the number
of sessions completed and, if applicable, the reasons for
not finishing the course. The questionnaire further re-
searches satisfaction with the separate elements of the
intervention, such as the quality of the feedback, the
clarity of the website and the appropriateness of the ex-
amples. Lastly, it explores whether participants were sat-
isfied with the provided alternative to waiting, to which
degree internet interventions are preferred over book in-
terventions and to which degree feedback is preferred
over non-feedback.
Kenter et al. Trials 2013, 14:412 Page 8 of 10
http://www.trialsjournal.com/content/14/1/412Statistical analysis
The analyses will be conducted in agreement with the
intention to treat (ITT) principle, as per the CONSORT
statement [34]. Therefore missing endpoints will be im-
puted using state of the art imputation methods, as a reli-
able method for handling missing values [35]. Imputation
allows for analyzing all participants in the condition to
which they have been randomized, which contributes to
guarantee the integrity of the randomization and restores
loss of power due to dropout.
To answer the research questions we will first look at
post-test differences between the two groups. We will use
analysis of variance (ANOVA), with the baseline values
and waiting time as covariates. Subgroup analyses will be
performed for different characteristics. The difference
in scores between the intervention group and the con-
trol group will also be expressed in effect sizes. We use
Cohen’s d which is calculated by dividing the difference
in mean scores of the two groups by their pooled stand-
ard deviation (Xexp-Xctrl/SDpooled). Effect sizes under
0.2 are considered to be small, those of 0.5 are moderate
and effect sizes of 0.8 are considered to be large [36].
Furthermore, we will compare the rate of DSM-IV diag-
nosis of depression in both groups with logistic regres-
sion analysis. The clinical effects will also be calculated
using reliable change [37]. The long-term outcomes will
be analyzed with longitudinal analyses.
Economic outcomes
The economic evaluation will be conducted from a societal
perspective, therefore it will include not only the interven-
tion costs and costs stemming from healthcare uptake (dir-
ect medical costs), but also the patients' out of pocket costs
(direct non-medical costs) and costs stemming from prod-
uctivity losses due to absenteeism and work cutback days
(indirect non-medical costs). Costs will be based on the
Dutch standard cost prices [24] and productivity losses will
be valued using the friction costs method, as per the Dutch
guideline for economic evaluation. Quality-adjusted life
years (QALYs) will be calculated on the basis of the
EQ-5D. Having calculated the costs and QALYs allows for
a cost-utility analysis, which can be used to compare this
intervention’s gains against those of other interventions
for depressive disorders. A cost-effectiveness analysis can
be carried out by dividing the difference in costs by the
difference in effect, as is customary in the field of mental
health. Bootstrapping will be used to ascertain the amount
of uncertainty surrounding the incremental cost effective-
ness ratio (ICER) estimates and graphically depicted on
the ICER plane and in the acceptability curve.
Discussion
This study will examine the effectiveness of offering an
internet-based guided self-help intervention to patientsbefore to start of face-to-face treatment in comparison with
patients who have to wait for face-to-face treatment. We
will also compare the uptake of regular treatment in both
groups. An economic evaluation will determine whether a
guided internet intervention followed by face-to-face treat-
ment is economically more sensible compared to waiting
for face-to-face treatment. A number of strengths and chal-
lenges have been identified by the researchers in this study.
Strengths
Existing evidence shows that internet-based treatments
are effective in treating depressive disorders in general
populations [9,38]. This trial however, will shed new
light on the question whether patients with major de-
pressive disorder waiting for specialized care in MHCs
can benefit from this type of internet-based guided self-
help intervention. This population has, to the best of
our knowledge, not previously been studied in this man-
ner, while the relevance of conducting a study on people
with major depressive disorder who receive an internet-
based intervention as a first step of treatment is high for
a number of reasons. As demonstrated previously, de-
pression is a widely prevalent, invasive disorder, which
affects the patients, their direct environments, and the
society as a whole in multiple ways. Any measures which
contribute to more people receiving better care for their
depression in specialized mental healthcare against a
lower costs will be welcomed by all stakeholders. Stepped
care is suggested for treating depression in multiple guide-
lines, for example the NICE guidelines in the UK (2009)
Although there is some supporting evidence, there are few
RCTs to demonstrate the (cost) effectiveness of this
program in specialized mental healthcare. Furthermore,
considering the increase of online interventions to the
standard treatment in more and more MHCs, this study
will contribute valuable information on the effects of
adding online treatment as a first step towards treating
major depressive disorder.
An additional strength of this intervention is the on-
line delivery. The online intervention allows participants
not only to access the intervention any convenient hour,
with the rise of portable internet there are hardly any
limitations related to the location of a participant. In
addition, offering guided online treatment during the
time otherwise lost to waiting may result in benefits for
the patient as well as for the MHCs in terms of patient
satisfaction and clinical effectiveness.
A final strength of this study is the possibility of ap-
plicability. If the study indicates that it is economically
and clinically beneficial to deliver internet interventions
to those with a major depressive disorder as part of their
treatment, the intervention could easily be integrated as
a standard component in the treatment of depression, as
only short training is necessary to become a successful
Kenter et al. Trials 2013, 14:412 Page 9 of 10
http://www.trialsjournal.com/content/14/1/412coach for this intervention. This intervention could be
applied widely in case the intervention is beneficial for
treating people with major depressive disorder.
Limitations
One of the possible challenges of this study concerns the
general attrition from and non-adherence to internet in-
terventions. Internet treatments require a degree of mo-
tivation of the participant. This study includes depressed
patients who, by definition, have impaired motivation
and lack of energy that may make it more difficult for
patients adhere to the intervention. To prevent dropouts
and maximize the uptake rates the participants will re-
ceive emails and phone calls stating the importance ad-
hering to the intervention.
Another challenge for the trial could be the prevailing
attitude of psychologists at several MHCs who fear re-
dundancy due to internet interventions. However, when
MHCs would start treating patients online as a first step
towards better health, more patients could be reached as
online treatment seems to be less time consuming for
health professionals compared to face-to-face treatment.
A further challenge is the extent the therapists take into
account that patients might already have acquired skills
and knowledge due to the internet intervention, so that
there might be no need to start patients a fixed number of
face-to-face sessions as prescribed by the standard treat-
ment protocol. We aim that only those patients who
require additional treatment due to a more complex
psychological problem will be seen face-to-face. There-
fore, if internet interventions are proven to be more
clinically effective, it is feasible that psychologists at
MHCs will be able to treat more patients in a better
manner because of the implementation of internet
interventions.
In summary, existing internet-based guided self-help
treatments focus mainly on depression in the general
population. This trial, however, is to the best of our
knowledge the first effectiveness study of an internet-
based guided self-help intervention for major depressive
disorder in specialized mental healthcare that also fo-
cuses on reduction of face-to-face sessions and costs in
general. The findings of this study will contribute to the
body of knowledge on the additional value of internet-
based treatments for depression. And if the low intensity
internet intervention shows to be (cost) effective, it might
serve as a first step towards the treatment of major de-
pressive disorder.
Trial status
The status of the trial is ongoing recruitment.
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